Anna D. Garrett, PharmD, BCPS, CPP
The findings of a 20-year
study of the inhabitants of
Olmsted County, Minn, showed
a sharp rise in new cases of atrial
fibrillation (AF). During the
study, 4618 new cases of electrocardiogram-
confirmed AF
were identified. The incidence of new AF,
measured in cases per 1000 person-years rose
approximately 20%. Based on these findings,
the group estimated that the current incidence
of AF in the United States is approximately 5.1
million, not 2.5 million as previously estimated.
The investigators projected that, by 2050, the
number of individuals with AF will increase to
12 million if the rate of new AF does not continue
to increase. If it does continue to rise, 16
million patients could be affected by 2050.
If their estimate of 5.1 million people with AF
in the United States is correct and if, as several
studies have found, about 50% of those do not
receive anticoagulation, it would be reasonable
to expect that failure to use anticoagulation
would produce approximately 125,000 strokes
per year. Warfarin is very effective for stroke
prevention and may reduce the risk by up to
83%. Greater awareness of the rise in AF prevalence
and more widespread use of warfarin in
appropriate patients have the potential to save
the health care system between $8.1 and
$10.5 billion annually.
The authors of the study suggest that
increasing obesity may account for as much as
60% of the increase.
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.